# CRISPR Therapeutics AG: Form 8-K, filed Jun 3, 2024

- Company: [CRISPR Therapeutics AG](/companies/crsp.md) (CIK 1674416)
- Form: 8-K
- Filed: 2024-06-03
- Accepted by EDGAR: Jun 3, 2024, 08:06 ET
- Period: 2024-05-30
- Accession: 0000950170-24-067660
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1674416/000095017024067660/crsp-20240530.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1674416/000095017024067660/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1674416/000095017024067660/crsp-20240530.htm

Filed Jun 3, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-067660. Last ingested by Listed: Nov 2, 2026, 20:24 ET. No prices; not investment advice.